| Fresenius Kabi Oncology has reported a sales turnover of Rs 121.79 crore and a net profit of Rs 4.88 crore for the quarter ended Mar '12. | | For the quarter ended Mar 2011 the sales turnover was Rs 89.88 crore and net profit was Rs 2.96 crore. |
|
| | Quarterly Results of Fresenius Kabi Oncology | -------- in Rs. Cr. -------- |
|
| Mar '11 | | | Dec '11 | Mar '12 | | Sales Turnover | 89.88 | | | 128.32 | 121.79 | | Other Income | 3.64 | | | 0.39 | 0.15 | | Total Income | 93.52 | | | 128.72 | 121.94 | | Total Expenses | 84.42 | | | 114.73 | 107.88 | | Operating Profit | 5.46 | | | 13.59 | 13.91 | | Profit On Sale Of Assets | -- | | | -- | -- | | Profit On Sale Of Investments | -- | | | -- | -- | | Gain/Loss On Foreign Exchange | -- | | | -- | -- | | VRS Adjustment | -- | | | -- | -- | | Other Extraordinary Income/Expenses | -- | | | -- | -- | | Total Extraordinary Income/Expenses | -- | | | -3.01 | 5.75 | | Tax On Extraordinary Items | -- | | | -- | -- | | Net Extra Ordinary Income/Expenses | -- | | | -- | -- | | Gross Profit | 9.10 | | | 13.98 | 14.06 | | Interest | -- | | | 1.59 | 5.90 | | PBDT | 9.09 | | | 9.39 | 13.90 | | Depreciation | 5.31 | | | 6.26 | 6.05 | | Depreciation On Revaluation Of Assets | -- | | | -- | -- | | PBT | 3.78 | | | 3.13 | 7.85 | | Tax | 0.82 | | | 1.73 | 2.97 | | Net Profit | 2.96 | | | 1.40 | 4.88 | | Prior Years Income/Expenses | -- | | | -- | -- | | Depreciation for Previous Years Written Back/ Provided | -- | | | -- | -- | | Dividend | -- | | | -- | -- | | Dividend Tax | -- | | | -- | -- | | Dividend (%) | -- | | | -- | -- | | Earnings Per Share | 0.19 | | | 0.09 | 0.31 | | Book Value | -- | | | -- | -- | | Equity | 15.82 | | | 15.82 | 15.82 | | Reserves | -- | | | -- | -- | | Face Value | 1.00 | | | 1.00 | 1.00 | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
